Credit:Healthreformwatch.comMonday, January 04, 2010
CMS and HHS Release New Proposed Rules Governing Health IT
By Jordan Cohen, Health Reform Watch
Issues surrounding the implementation of health information technology (HIT) have not garnered anywhere near the amount of attention as issues such as the public plan, the intersection of abortion and health insurance, pre-existing condition provisions, etc. There are a variety of reasons for this.
Read more at Health Reform Watch…
Filed under: Digital records, Health Reform, Weekly Round Up
by
admin
at 10:54 am 01.04.10
Keywords: Health 2.0, Health Reform
Credit:FDASM.comFriday, November 13, 2009
HF Exclusive: From the Floor of the FDA Social Media Hearing
To expand on our midday post, the Ruder Finn senior staff provides another look at the conversations surrounding adverse events reporting at today’s FDA public hearing on the use of social media by the pharmaceutical industry:
While we discussed the potential pitfalls and challenges that lie ahead in adapting the FDA’s standing adverse events (AEs) reporting 
Filed under: Drugs, FDA
by
admin
at 6:22 pm 11.13.09
Keywords: FDASM, Health 2.0
Credit:FDASM.comFriday, November 13, 2009
HF Exclusive: From the Floor of the FDA Social Media Hearing
After this morning’s lively discussion on adverse event reporting, the Ruder Finn senior staff provides another look at the unfolding conversations at this week’s FDA public hearing on the use of social media by the pharmaceutical industry:
When discussing the proposed adjustments to online adverse events (AE) reporting, it’s important to define current FDA guidelines on
Filed under: Drugs, FDA
by
admin
at 1:37 pm 11.13.09
Keywords: FDASM, Health 2.0
Credit:FDASM.comFriday, November 13, 2009
FDASM: Google’s Pitch to FDA for Online Drug Ads
By Jacob Goldstein, WSJ Health Blog
Sure, dozens of groups are speaking at this week’s FDA meeting on online advertising for drugs and medical devices.
But we’re particularly interested in what Google had to say, given the company’s 800-pound-gorilla status in online advertising — as well as the flurry of FDA warning letters earlier this year
Filed under: Drugs, FDA, Weekly Round Up
by
admin
at 11:33 am 11.13.09
Keywords: FDASM, Health 2.0
Credit:FDASM.comFriday, November 13, 2009
FDASM: Day One in DC: Industry bends FDA’s ear on social media
By Matthew Arnold, Medical Marketing & Media
The FDA’s hearings on promotion of regulated products online and using social media—the “Super Bowl of Part 15 Hearings,” as Porter Novelli’s Peter Pitts dubbed them—got under way yesterday in a near-capacity federal conference hall. More than 800 people had tried to register, said DDMAC director Thomas Abrams, and
Filed under: Drugs, FDA, Weekly Round Up
by
admin
at 11:31 am 11.13.09
Keywords: FDASM, Health 2.0
